The aim of the study was to determine mitomycin-C (MMC) concentrations in human aqueous humour during trabeculectomy and to correlate anterior cham ber concentrations with method of application. MMC was applied intra-operatively by saturating sponges, ranging in size from 2 x 2 x 5 mm to 2 x 4 x 10 mm on dry cut, with 0.5 mg/ml MMC during trabeculectomy for 3-5 minutes. Applications to episclera were made in 18 cases and to the scleral bed after scleral flap dissection in 9
activity. In ophthalmology MMC has been used topically to suppress recurrence after pterygium surgery,4-6 to decrease the risk of glaucoma filtration bleb failure,7-9 and as a modulator of corneal wound healing following excimer photorefractive surgery, IO In trabeculectomy, MMC applied intra-operatively at the filtration site reduces subconjunctival scarring and enhances the success rate,7-9 while causing few intraocular complications.9,11,I2 MMC does, however, have the poten tial for endothelial toxicity, as demonstrated by Derick and co-workers,3 who injected MMC intracamerally in rabbit eyes. They reported that small amounts of MMC can be harmful to corneal endothelial cells if it gains entry to the anterior chamber during surgery. Serious complications related to local ocular toxicity, such as scleral and corneal ulceration, scleromalacia, necrotising scleritis, uveitis, symblepharon and scleral calcification, are reported fol lowing topical use of MMC in pterygium surgery.6,14-17 Due to the relatively short clinical experience, the safety of this drug in glaucoma filtration surgery has not been investigated extensively. To our knowledge, the actual concentration of MMC in human aqueous humour fol lowing its application during trabeculectomy has not been determined. In the study described here we determined MMC concentrations in human aqueous samples col lected intra-operatively and correlated the concentration levels with various methods of application.
PATIENTS AND METHODS
Twenty-seven patients with medically uncontrolled glau coma, who required trabeculectomy with adjunctive MMC therapy between 28 October 1992 and 5 February 1993 were studied. Not included were patients who refused consent and those with pre-existing shallow anterior chambers.
Standard trabeculectomy was performed by one of four experienced glaucoma surgeons (D.S.M., G.B., D.K.H. or P.P.L.) at the Doheny Eye Institute. Surgical techniques were similar in all cases except for variations in the method for MMC application. Sponges (Mentor, Norwell, Mass., USA), with sizes ranging from 2 x 2 x 5 mm to 2 x 4 x 10 mm on dry cut, were saturated thoroughly in a solution of 0.5 mg/ml of MMC (Bristol Laboratories, Evansville, Ind., USA) prior to application. A MMC soaked sponge was placed directly on the episclera before the scleral dissection in 18 cases, and in the scleral bed after dissection of the scleral flap in 9 cases. The sponge remained in place for 3 minutes in 8 cases and 5 minutes in 19 cases. The size of sponge, site of application and dura tion of exposure were determined by the surgeon's prefer ence. The study protocol was approved by the University of Southern California School of Medicine Research Committee (research protocol no. 92B003), and all patients gave informed consent. Aqueous humour samples (50-150 j..! I) were collected by paracentesis using a 30 gauge needle on a tuberculin syringe 2-7 minutes after removal of the sponge and following copious external irri gation. The samples were stored immediately at -70°C and MMC concentrations were determined by a specific high-performance liquid chromatographic (HPLC) method within 48 hours of collection.
HPLC Methodfor Determination of MMC in Aqueous Humour18-21
MMC was determined in aqueous humour by a modi fication of the HPLC method of Buice et al. 18 A solution of the internal standard, p-aminoacetophenone, 5 j..! g/ml was added to 100 j..! l of aqueous humour and the mixture shaken. An appropriate volume of this solution was injected directly into the HPLC and separated using a 4.6 x 50 mm, 3 j..! m particle size, C18 reverse-phase column (Microsorb 'Short One'), preceded by a C18 guard column (both Microsorb C 18, Rainin Instruments, Woburn, Mass., USA), and detected at an analytical wave length of 365 nm. The mobile phase consisted of a mix ture of methanol:water (28:72), containing 10 mM amm onium hydrogen phosphate, adjusted to pH 7.0.
The retention times for MMC and internal standard were 2.69 and 2.34 minutes respectively. The validated method was linear over a concentration range of 6-250 ng/ml, with a minimum detectable concentration in aque ous humour of 5 ng/mt.
Estimation of MMC Dose Delivered During Intra operative Applications
The amount of MMC saturated in each piece of sponge (dose) used in applications during surgery was estimated to be 0.47 j..! g/mm3, on the basis of the mean weight differ ence between a wet and a dry sponge. MMC dose for sponge size 2 x 2 x 5 mm was approximately 9.4 j..! g, for 2 x 4 x 6 mm was 22.6 j..! g, for 2 x 5 x 6 mm was 28.2 j..! g, and for 2 x 4 x 10 mm was 3.76 j..! g.
Statistical Method
Student's t-test was used to compare the difference between various test groups. A p value of less than 0.05 was considered statistically significant.
RESULTS
Patients ranged in age from 2 to 85 years (mean ± SD, 56.65 ± 20.16 years). Fourteen patients had primary open angle glaucoma, 4 had angle closure glaucoma, 4 had pseudophakic glaucoma, 3 had secondary glaucoma, 1 had neovascular glaucoma and 1 had congenital glau coma. Only 1 patient had an intra-operative complication: vitreous loss, after iridectomy, several minutes after aque ous sampling.
Aqueous MMC concentrations from the 27 cases are summarised in Table I . The mean aqueous drug concen tration after an episcleral application was 4.98 ± 9.11 ng/ml (range 0-33.3 ng/mI), whereas that following scleral bed application was 35.65 ± 39.17 ng/ml (range 5-120.8 ng/ml). The difference between the means of the two groups is statistically significant (p = 0.004). 
DISCUSSION
We have demonstrated that MMC is detectable in human aqueous humour within minutes after external application to the sclera. The mean concentration following scleral bed application (35.65 ng/ml) is slightly lower than that reported by Kawase and co-workers21 in their experi mental study on rabbit eyes despite the higher drug con centration used in our study (0.5 mg/ml vs. 0.2 mg/rnl). This difference may have related to the timing of aqueous sample collection. The collection time in our study was between 2 and 7 minutes after removal of the sponge, which may be before the peak concentration is achieved. In their rabbit study, Kawase et al. 21 showed concentration levels in aqueous of 0, 90, 110, 30, 20 and 0 ng/ml at 0, 30, 60, 120, 180 and 360 minutes, respectively, with the peak at 30-60 minutes after application. MMC requires time to diffuse through the ocular tissues to reach peak concen trations in aqueous humour; after this the concentration declines over time, presumably as it is being cleared via the surgical filtration channel, trabecular meshwork and other outflow pathways.
The range of concentrations varies widely in our samples because the concentration level is influenced by many factors, including MMC dose, concentration of drug used, duration of exposure, site of application and perhaps anatomical or physiological variations. The method of MMC application used by some of the surgeons involved in the present study is a modification of that described in the literature.7-9,11,12,22 In 18 of our cases the sponge was placed on the episclera prior to scleral flap dissection, and in 9 of the cases application was made after scleral flap dissection, with the sponges placed either on or under the scleral flap, as described in the literature.7-9,l1,12,22 Lower concentrations of MMC in the aqueous were achieved with the episcleral application method.
The effects, if any, on corneal endothelial cells of MMC at the concentrations attained with these two techniques are currently unknown, but in vitro and clinical inves tigations are being conducted to determine whether such exposure could adversely affect the endothelium.
